1% Acyclovir Eye Drops 10mL | Antiviral Medication for Ocular Herpes Infections

Acyclovir Eye Drops
  • Concentration: 1% Acyclovir (1 mg/ml)
  • Volume: 5ml or 10ml per bottle
  • Packaging: Sterile plastic dropper bottle, 1 bottle/box
  • Shelf Life: 24 months (unopened)

Click to add this item to cart.

Product Description

Product Name1% Acyclovir Eye Drops 10mL (Acyclovir Ophthalmic Solution)
Specification10mL sterile eye drops containing 1% (10 mg/mL) Acyclovir
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientAcyclovir (Antiviral Agent — Nucleoside Analogue)
Pharmacological ClassAntiviral Ophthalmic Agent (Nucleoside Analogue)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 1-2 hours initially, then reduced as directed.
PackagingSterile multi-dose dropper bottle (10mL) with tamper-evident seal
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Shelf Life24 months unopened; discard within 4 weeks of first opening

Product Overview

1% Acyclovir Eye Drops is a sterile ophthalmic solution containing 1% (10 mg/mL) acyclovir. It is an antiviral eye drop used for the topical management of viral eye infections affecting the ocular surface.

1% Acyclovir Eye Drops 10mL: What the Published Guidance Says

Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.

This page collects the supply-relevant facts for 1% Acyclovir Eye Drops 10mL — specification, testing, packaging and the registration paperwork that travels with the batch.

  • Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
  • Ofloxacin 0.3% — for keratitis, and extended to conjunctivitis Ofloxacin eye drops 0.3% are listed for infectious keratitis, and in 2021 the Expert Committee recommended expanding the indication to include conjunctivitis. Topical fluoroquinolones are the class the Committee endorsed for infectious keratitis. WHO eEML — Ofloxacin (ophthalmological)
  • Gentamicin eye drops 0.3% are on the Model List for ocular infection WHO lists gentamicin eye drops 0.3% (gentamicin sulfate) for infectious blepharitis, classified in the Access group of the AWaRe framework. The Expert Committee has specified amikacin, kanamycin, netilmicin and tobramycin as therapeutic alternatives under the gentamicin square-box listing. WHO eEML — Gentamicin (ophthalmological)

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for 1% Acyclovir Eye Drops 10mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

1% Acyclovir Eye Drops 10mL: Specification, Pack & Documentation Summary

Product Name1% Acyclovir Eye Drops 10mL (Acyclovir Ophthalmic Solution)
Specification10mL sterile eye drops containing 1% (10 mg/mL) Acyclovir
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientAcyclovir (Antiviral Agent — Nucleoside Analogue)
Pharmacological ClassAntiviral Ophthalmic Agent (Nucleoside Analogue)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 1-2 hours initially, then reduced as directed.
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Therapeutic groupOphthalmic — Ophthalmic
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL, 5% Taurine Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.3% Gentamicin Eye Drops 10mL, 0.5% Hypromellose Eye Drops 10mL, 0.5% Kanamycin Eye Drops 10mL, 2.5% Lincomycin Hydrochloride Eye Drops 10mL, 0.5% Moxifloxacin Hydrochloride Eye Drops 10mL.

How 1% Acyclovir Eye Drops 10mL Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of 1% Acyclovir Eye Drops 10mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How 1% Acyclovir Eye Drops 10mL Is Packed, Labelled and Shipped

  • Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
  • Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for 1% Acyclovir Eye Drops 10mL

Documents for 1% Acyclovir Eye Drops 10mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.

The context for 1% Acyclovir Eye Drops 10mL is its place among ophthalmic preparations used in WHO and MSF eye-care protocols. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Questions We Are Asked About 1% Acyclovir Eye Drops 10mL

What pack size is available for 1% Acyclovir Eye Drops 10mL?

This presentation is normally supplied as Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of 1% Acyclovir Eye Drops 10mL?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening.

Does the batch documentation for 1% Acyclovir Eye Drops 10mL support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Can you supply trypan blue for cataract surgery?

Yes. Trypan blue ophthalmic solution is available for capsule staining, supplied with sterility documentation.

What documentation accompanies an ophthalmic order?

Batch COA covering assay, sterility and preservative content, plus stability data, DMF and dossier packages with registration support documents.

Companion Products — Ophthalmic

Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.

Request a Quotation for 1% Acyclovir Eye Drops 10mL

For tenders and programme supply, send the line item, pack size, quantity and destination for 1% Acyclovir Eye Drops 10mL 10mL. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products